Leveraging Alzheon experience
A leader in Alzheimer’s science & therapeutics
Martin Tolar, MD, PhD
- Founder of Tolion Health, Inc.
- Founder of INDRC institute
- AI in neurodegenerative disorders
- Founder & CEO of Alzheon, Inc.
- CEO of NormOxys, Inc. & Knome, Inc.
Alzheon
- Discovered Alzheimer’s disease toxin
- Leading investigational treatment ALZ-801
- Tolion app – synergistic product with ALZ-801
- Collaboration with Alzheon channels & payers
Alzheimer’s dementia is preceded by a long silent pre-symptomatic phase
